Annual CFO
-$31.43 M
+$19.76 M+38.60%
31 December 2023
Summary:
NexImmune annual cash flow from operations is currently -$31.43 million, with the most recent change of +$19.76 million (+38.60%) on 31 December 2023. During the last 3 years, it has fallen by -$5.03 million (-19.03%). NEXI annual CFO is now -182.69% below its all-time high of -$11.12 million, reached on 31 December 2018.NEXI Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$2.07 M
+$343.70 K+14.23%
30 June 2024
Summary:
NexImmune quarterly cash flow from operations is currently -$2.07 million, with the most recent change of +$343.70 thousand (+14.23%) on 30 June 2024. Over the past year, it has increased by +$5.21 million (+71.55%). NEXI quarterly CFO is now at all-time high.NEXI Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$17.61 M
+$3.96 M+18.35%
30 June 2024
Summary:
NexImmune TTM cash flow from operations is currently -$17.61 million, with the most recent change of +$3.96 million (+18.35%) on 30 June 2024. Over the past year, it has increased by +$19.12 million (+52.06%). NEXI TTM CFO is now -170.42% below its all-time high of -$6.51 million, reached on 31 March 2020.NEXI TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NEXI Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.6% | +71.5% | +52.1% |
| 3 y3 years | -19.0% | +78.4% | +57.6% |
| 5 y5 years | -182.7% | - | - |
NEXI Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -19.0% | +38.6% | at high | +87.4% | at high | +65.8% |
| 5 y | 5 years | -182.7% | +38.6% | at high | +87.4% | -170.4% | +65.8% |
| alltime | all time | -182.7% | +38.6% | at high | +87.4% | -170.4% | +65.8% |
NexImmune Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$2.07 M(-14.2%) | -$17.61 M(-18.4%) |
| Mar 2024 | - | -$2.42 M(-58.6%) | -$21.56 M(-31.4%) |
| Dec 2023 | -$31.43 M(-38.6%) | -$5.83 M(-19.9%) | -$31.43 M(-14.4%) |
| Sept 2023 | - | -$7.28 M(+20.8%) | -$36.72 M(-11.1%) |
| June 2023 | - | -$6.03 M(-50.9%) | -$41.31 M(-12.1%) |
| Mar 2023 | - | -$12.28 M(+10.4%) | -$47.00 M(-8.2%) |
| Dec 2022 | -$51.19 M(+11.8%) | -$11.13 M(-6.2%) | -$51.19 M(-0.6%) |
| Sept 2022 | - | -$11.87 M(+1.2%) | -$51.50 M(+4.7%) |
| June 2022 | - | -$11.72 M(-28.8%) | -$49.22 M(-3.7%) |
| Mar 2022 | - | -$16.48 M(+44.0%) | -$51.11 M(+11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$45.79 M(+73.4%) | -$11.44 M(+19.4%) | -$45.79 M(+10.2%) |
| Sept 2021 | - | -$9.58 M(-29.7%) | -$41.54 M(+7.5%) |
| June 2021 | - | -$13.61 M(+22.0%) | -$38.66 M(+24.5%) |
| Mar 2021 | - | -$11.16 M(+55.1%) | -$31.05 M(+17.6%) |
| Dec 2020 | -$26.40 M(+36.0%) | -$7.19 M(+7.4%) | -$26.40 M(+37.4%) |
| Sept 2020 | - | -$6.70 M(+11.5%) | -$19.21 M(+53.5%) |
| June 2020 | - | -$6.01 M(-7.7%) | -$12.52 M(+92.3%) |
| Mar 2020 | - | -$6.51 M | -$6.51 M |
| Dec 2019 | -$19.42 M(+74.6%) | - | - |
| Dec 2018 | -$11.12 M | - | - |
FAQ
- What is NexImmune annual cash flow from operations?
- What is the all time high annual CFO for NexImmune?
- What is NexImmune annual CFO year-on-year change?
- What is NexImmune quarterly cash flow from operations?
- What is the all time high quarterly CFO for NexImmune?
- What is NexImmune quarterly CFO year-on-year change?
- What is NexImmune TTM cash flow from operations?
- What is the all time high TTM CFO for NexImmune?
- What is NexImmune TTM CFO year-on-year change?
What is NexImmune annual cash flow from operations?
The current annual CFO of NEXI is -$31.43 M
What is the all time high annual CFO for NexImmune?
NexImmune all-time high annual cash flow from operations is -$11.12 M
What is NexImmune annual CFO year-on-year change?
Over the past year, NEXI annual cash flow from operations has changed by +$19.76 M (+38.60%)
What is NexImmune quarterly cash flow from operations?
The current quarterly CFO of NEXI is -$2.07 M
What is the all time high quarterly CFO for NexImmune?
NexImmune all-time high quarterly cash flow from operations is -$2.07 M
What is NexImmune quarterly CFO year-on-year change?
Over the past year, NEXI quarterly cash flow from operations has changed by +$5.21 M (+71.55%)
What is NexImmune TTM cash flow from operations?
The current TTM CFO of NEXI is -$17.61 M
What is the all time high TTM CFO for NexImmune?
NexImmune all-time high TTM cash flow from operations is -$6.51 M
What is NexImmune TTM CFO year-on-year change?
Over the past year, NEXI TTM cash flow from operations has changed by +$19.12 M (+52.06%)